5.2/10
Weak

Epitalon

Epitalon · Tetrapeptide · Longevity / Circadian

The longevity peptide that keeps showing up in telomere conversations for a reason, then gets sold far past that reason. Interesting, still unsettled.

Cost / mo
$70–130
Forms
SubQ
Onset
Cycle-based
Cycle
10–20 day cycles
Studies
15+

Should you care about Epitalon?

You should care if you track longevity peptides closely and want to separate the truly interesting compounds from the truly oversold ones. Epitalon qualifies as both.

You should stay measured because intriguing aging biology is not the same thing as proven human life extension. That distinction matters a lot here.

What the internet says

"Epitalon is basically one of the few real life-extension peptides."

What the data says

It is one of the more interesting longevity candidates, but the human evidence is not strong enough to speak that confidently.

What it actually does (ranked by evidence)

1

Longevity-Pathway SupportWeak

This is why the peptide remains relevant at all. The problem is that relevance is not the same thing as reliable proof.

2

Circadian and Sleep SupportWeak

Interesting enough to monitor in practice, not strong enough to center the whole pitch around.

Dosing

Longevity peptides are easy to mythologize because the outcomes are subtle and hard to verify. Keep the confidence level honest.
Oral
No standard oral form

Epitalon is generally discussed as an injectable cycle rather than a continuous oral intervention.

Injectable
5–10 mg daily for 10–20 days

Short, periodic cycles are the norm in longevity-focused protocols.

If a longevity outcome cannot be measured clearly, it becomes especially important not to let enthusiasm write the conclusion first.

Side effects: the honest version

✓ Confirmed safe
  • ✓Injection-site irritation
  • ✓Headache
  • ✓Sleep-pattern changes in some users
! Unknown
  • iBenefit is hard to measure in the short term.
  • iProtocol confidence depends heavily on how much extrapolation you are willing to accept.
  • iLongevity claims should be handled more cautiously than the market usually allows.

The studies that matter

We read all 15+. These are the three we'd cite first.

Epitalon and telomere-related aging literature

Weak
Longevity and translational aging reports · 2000s–2010s
Result: Interesting mechanistic and translational signal with substantial room for caution

Circadian and pineal-function observations

Weak
Experimental aging literature · 2000s
Result: Hypothesis-generating support, limited modern outcome certainty
View all 15+ studies

How it stacks up

Longevity peptide comparison. No hedging.

Epitalon
NAD+
DSIP
Score
5.2
5.5
4.8
Evidence
Weak
Weak
Weak
Oral?
No
No
No
Cost / mo
$70–130
$200–800
$50–90
Best for
Longevity-oriented experimental protocols
Energy-oriented longevity
Sleep-first experimentation
Our pick?
Situational
Different niche
Narrower target

Questions people actually ask

Answers that don't insult your intelligence.

No. It is better described as a longevity peptide with suggestive biology and limited certainty than as a proven anti-aging therapy.
★ Bottom Line

Epitalon is one of the more intellectually interesting longevity peptides. It is also one of the easiest to overstate. Curious compound, cautious confidence.

— PepTalk Editorial Team · April 2026